DB-1314

N/A

Report date: 2024/07/25 15:06:31

Base Information

Drug NameDB-1314
Drug Alias NameDB-1314
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-Delta-like protein 3DNA topoisomerase I inhibitors
TargetsDelta-like protein 3DNA topoisomerase I
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesDuality Biologics (Shanghai) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDuality Biologics (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A